PRDX6 inhibits hepatic stellate cells activation and fibrosis via promoting MANF secretion
Authors:
Open Access
- 29 October 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 156, 113931
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81973336)
- National Natural Science Foundation of China (U21A20345)
- Anhui Medical University
This publication has 46 references indexed in Scilit:
- Intracellular targeting of peroxiredoxin 6 to lysosomal organelles requires MAPK activity and binding to 14-3-3εAmerican Journal of Physiology-Cell Physiology, 2011
- Novel CDNF/MANF family of neurotrophic factorsDevelopmental Neurobiology, 2010
- Identification of the amino acid sequence that targets peroxiredoxin 6 to lysosome-like structures of lung epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Induction Profile of MANF/ARMET by Cerebral Ischemia and its Implication for Neuron ProtectionJournal of Cerebral Blood Flow & Metabolism, 2009
- Angiotensin II Activates IκB Kinase Phosphorylation of RelA at Ser536 to Promote Myofibroblast Survival and Liver FibrosisGastroenterology, 2009
- Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Nuclear and cytoplasmic peroxiredoxin-1 differentially regulate NF-κB activitiesFree Radical Biology and Medicine, 2007
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- A C-terminal signal prevents secretion of luminal ER proteinsCell, 1987